Saturday, 27 October 2012

Current hot topics for regulatory professionals


Article from TOPRA,  Regulatory Rapporteur – Vol 9, No 11, November 2012. 

Authors

Patricia Duchêne, Director Regulatory Affairs, Celgene Corporation, US; Monique Garrett, CEO, PrismWorks, LLC; 
Sara Snow, Senior Associate II, Regulatory Development, Biogen Idec

This article represents views of senior US regulatory leaders on current hot topics for regulatory professionals.
  • What is the biggest challenge you see facing the US regulatory affairs community in the coming year? 
  • Are you witnessing any new trends in the regulatory affairs arena that you think will impact approval processes in the US? 
  • How do you think agency/sponsor relations will change in the coming year?
  • Do you have any advice for regulatory professionals who may be planning on submitting in the US?
Reference: All in a day’s work

2 comments:

  1. Implementation of generic user feet act , will be the major challenge to the US FDA authority this coming year i guess.

    ReplyDelete
    Replies
    1. Hi
      yes correct.
      Check it once reference file "All in a day’s work".

      Delete